
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say
By Kane Wu HONG KONG (Reuters) – Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan’s Mitsubishi Chemical Group, in a deal that could value it at between $3 billion and $3.5 billion, three sources said. Mitsubishi Chemical has hired Goldman Sachs to run…